Tauro-obeticholic acid
Tauro-obeticholic acid is an active metabolite of Obeticholic acid. Obeticholic acid is an orally bioavailable farnesoid-X receptor (FXR) agonist[1].
Product Specifications
CAS Number
[863239-61-6]
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
FXR
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/tauro-obeticholic-acid.html
Purity
98.2
Solubility
10 mM in DMSO
Smiles
C[C@H](CCC(NCCS(=O)(O)=O)=O)[C@H]1CC[C@@]2([H])[C@]3([H])[C@H](O)[C@H](CC)[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C
Molecular Formula
C28H49NO6S
Molecular Weight
527.76
Precautions
H302, H315, H319, H335
References & Citations
[1]Markham A, et al. Obeticholic Acid: First Global Approval. Drugs. 2016 Aug;76 (12) :1221-6.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral mouse C530008M17Rik shRNA (UAS) - Lentiviral mouse C530008M17Rik shRNA (UAS) (25)
Mouse Monoclonal pan Actin Antibody (MSA/953) [Allophycocyanin/Cy7]
